发明名称 |
CRYSTALLINE FORM OF OXAZOLIDINONE ANTIBIOTICS AND PREPARATION METHOD, COMPOSITION AND USE THEREOF |
摘要 |
The present invention relates to a novel crystal form of oxazolidinone antibiotics. The new crystalline form has advantages in the aspects of solubility, hygroscopicity, crystallinity and stability. The present invention also relates to a method for preparing the new crystalline form, a pharmaceutical composition thereof and the use thereof in the preparation of drugs for treating and/or preventing diseases caused by microbial infection. |
申请公布号 |
US2017008919(A1) |
申请公布日期 |
2017.01.12 |
申请号 |
US201515119490 |
申请日期 |
2015.03.27 |
申请人 |
HANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO., LTD. |
发明人 |
SHENG Xiaoxia;SHENG Xiaohong;ZHU Tao;JIA Qiang |
分类号 |
C07F9/6558;A61K9/20;A61K9/28;A61K31/675 |
主分类号 |
C07F9/6558 |
代理机构 |
|
代理人 |
|
主权项 |
1. Form II of (R)-3-(4-(2-(2-methyltetrazol-5-yl) pyridine-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate represented by the following structural formula:measured with Cu-Kα radiation, the X-ray powder diffraction pattern of the Form II, expressed as 2θ angles, has the following characteristic peaks: 10.5±0.2°, 15.7±0.2°, 16.5±0.2°, 17.3±0.2°, 21.0±0.2° and 26.3±0.2°. |
地址 |
Hangzhou, Zhejiang CN |